Latest Breaking News On - Nuvectis pharma daily - Page 1 : vimarsana.com

Nuvectis Pharma, Inc (NASDAQ:NVCT) Short Interest Up 18 8% in November

Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Free Report) was the target of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 345,600 shares, a growth of 18.8% from the October 31st total of 291,000 shares. Currently, 5.6% of the shares of the stock are […]

United statesNuvectis pharmaBaldwin brothersTower research capitalCharles schwab investment management incNuvectis pharma incGet free reportPharma stock downResearch capitalSchwab investment managementCalifornia state teachers retirement systemNuvectis pharma dailyNasdaq nvct

Nuvectis Pharma, Inc (NASDAQ:NVCT) Sees Significant Growth in Short Interest

Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Free Report) saw a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 345,600 shares, a growth of 18.8% from the October 31st total of 291,000 shares. Based on an average daily trading volume, of 46,300 shares, the short-interest […]

United statesNuvectis pharmaCitigroup incNuvectis pharma incCharles schwab investment management incGet free reportStreet corpSchwab investment managementState teachers retirement systemStrs ohioPharma trading downNuvectis pharma dailyNasdaq nvct

Insider Buying: Nuvectis Pharma, Inc (NASDAQ:NVCT) Major Shareholder Acquires $11,936 80 in Stock

Insider Buying: Nuvectis Pharma, Inc (NASDAQ:NVCT) Major Shareholder Acquires $11,936 80 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Marlio charles mosseriNuvectis pharmaNuvectis pharma incTower research capitalNuvectis pharma company profileVirtu financialBlackrock incGet free reportCharles mosseriResearch capitalStreet corpJane street groupNuvectis pharma daily

Marlio Charles Mosseri Buys 860 Shares of Nuvectis Pharma, Inc (NASDAQ:NVCT) Stock

Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Free Report) major shareholder Marlio Charles Mosseri acquired 860 shares of Nuvectis Pharma stock in a transaction that occurred on Monday, July 31st. The shares were bought at an average price of $13.88 per share, for a total transaction of $11,936.80. Following the transaction, the insider now owns 2,595,000 […]

Nova scotiaMarlio charles mosseriNuvectis pharmaBlackrock incNuvectis pharma company profileGeode capital managementNuvectis pharma incGet free reportCharles mosseriMontreal canStreet groupStreet corpCapital managementNuvectis pharma dailyNasdaq nvctInsider trading

Nuvectis Pharma, Inc (NASDAQ:NVCT) Major Shareholder Buys $77,673 60 in Stock

Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Free Report) major shareholder Marlio Charles Mosseri bought 5,394 shares of the business’s stock in a transaction that occurred on Thursday, July 20th. The stock was acquired at an average cost of $14.40 per share, with a total value of $77,673.60. Following the completion of the acquisition, the insider […]

Marlio charles mosseriNuvectis pharmaBlackrock incNuvectis pharma incTower research capitalGeode capital managementNuvectis pharma company profileVanguard group incGet free reportCharles mosseriStreet corpResearch capitalCapital managementVanguard groupNuvectis pharma dailyNasdaq nvct